Literature DB >> 25603001

An overview of treatments for endometriosis.

Julie Brown1, Cynthia Farquhar2.   

Abstract

CLINICAL QUESTION: What treatments are associated with improved outcomes for women with endometriosis? BOTTOM LINE: The levonorgestrel-releasing intrauterine system (LNG-IUD), gonadotropin-releasing hormone analogues (GnRHa; nafarelin, leuprolide, buserelin, goserelin, triptorelin), laparoscopic ablation, and excision are associated with relief of pain due to endometriosis. Gonadotropin-releasing hormone analogues and laparoscopic ablation or excision are associated with increased clinical pregnancy rates in women with endometriosis. Gonadotropin-releasing hormone analogues, danazol, and depot progestagens are associated with a higher incidence of adverse events.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25603001     DOI: 10.1001/jama.2014.17119

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  17 in total

Review 1.  Endometriosis: where are we and where are we going?

Authors:  Alexis D Greene; Stephanie A Lang; Jessica A Kendziorski; Julie M Sroga-Rios; Thomas J Herzog; Katherine A Burns
Journal:  Reproduction       Date:  2016-05-10       Impact factor: 3.906

2.  Seeing red: diet and endometriosis risk.

Authors:  Rosalia C M Simmen; Angela S Kelley
Journal:  Ann Transl Med       Date:  2018-12

3.  Endometriotic cyst fluid induces reactive oxygen species (ROS) in human immortalized epithelial cells derived from ovarian endometrioma.

Authors:  Yoichi Kobayashi; Kiyono Osanai; Kei Tanaka; Yoshiko Nishigaya; Hironori Matsumoto; Mai Momomura; Masamichi Hashiba; Shizuka Mita; Satoru Kyo; Mitsutoshi Iwashita
Journal:  Redox Rep       Date:  2016-11-20       Impact factor: 4.412

4.  Bis-Indole-Derived Nuclear Receptor 4A1 (NR4A1, Nur77) Ligands as Inhibitors of Endometriosis.

Authors:  Kumaravel Mohankumar; Xi Li; Nuri Sung; Yeon Jean Cho; Sang Jun Han; Stephen Safe
Journal:  Endocrinology       Date:  2020-04-01       Impact factor: 4.736

5.  ARID1A and PGR proteins interact in the endometrium and reveal a positive correlation in endometriosis.

Authors:  Hong Im Kim; Tae Hoon Kim; Jung-Yoon Yoo; Steven L Young; Bruce A Lessey; Bon Jeong Ku; Jae-Wook Jeong
Journal:  Biochem Biophys Res Commun       Date:  2021-03-09       Impact factor: 3.575

6.  Baicalein reduces endometriosis by suppressing the viability of human endometrial stromal cells through the nuclear factor-κB pathway in vitro.

Authors:  Zhixing Jin; Jianqin Huang; Zhiling Zhu
Journal:  Exp Ther Med       Date:  2017-08-01       Impact factor: 2.447

Review 7.  Intrauterine levonorgestrel delivery with frameless fibrous delivery system: review of clinical experience.

Authors:  Dirk Wildemeersch; Amaury Andrade; Norman D Goldstuck; Thomas Hasskamp; Geert Jackers
Journal:  Int J Womens Health       Date:  2017-01-21

8.  Behavioral and neurobiological effects of GnRH agonist treatment in mice-potential implications for puberty suppression in transgender individuals.

Authors:  Christoph Anacker; Ezra Sydnor; Briana K Chen; Christina C LaGamma; Josephine C McGowan; Alessia Mastrodonato; Holly C Hunsberger; Ryan Shores; Rushell S Dixon; Bruce S McEwen; William Byne; Heino F L Meyer-Bahlburg; Walter Bockting; Anke A Ehrhardt; Christine A Denny
Journal:  Neuropsychopharmacology       Date:  2020-09-12       Impact factor: 7.853

9.  Effectiveness of Puberty Suppression with Gonadotropin-Releasing Hormone Agonists in Transgender Youth.

Authors:  Juan Diego Mejia-Otero; Perrin White; Ximena Lopez
Journal:  Transgend Health       Date:  2021-02-15

Review 10.  Models of endometriosis and their utility in studying progression to ovarian clear cell carcinoma.

Authors:  Claire M King; Cynthia Barbara; Andrew Prentice; James D Brenton; D Stephen Charnock-Jones
Journal:  J Pathol       Date:  2016-01       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.